Wednesday, 31 May 2023
Trending

Investing

Morgan Stanley maintains Marvell at 'equalweight' with a price target of $55.00

Goldman Sachs Downgrades Elanco Animal Health to Sell



Morgan Stanley maintains Marvell at 'equalweight' with a price target of $55.00

Click Here to Read the Full Original Article at All News…